Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
20 hedge funds and large institutions have $291K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
5% less funds holding
Funds holding: 21 → 20 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
95% less capital invested
Capital invested by funds: $6.3M → $291K (-$6.01M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICP
ION Crossover Partners
Herzliya Pituach,
Israel
|
+$118K |
| 2 |
UID
Union Investments & Development
Tel Aviv,
Israel
|
+$2.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$3.99M |
| 2 |
IAC
ION Acquisition Corp
Herzliya,
Israel
|
-$828K |
| 3 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
-$10.4K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1K |
| 5 |
SRFM
Shannon River Fund Management
New York
|
-$604 |
CTV.WS Hedge Fund Activity: Q2 2023 in Review
20 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q2 2023, worth a combined $291K — down 95% from $6.3M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CTV.WS and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was ION Crossover Partners, opening a new position worth an estimated $118K. The largest seller was BAMCO Inc, exiting entirely with an estimated $3.99M sold.
- 20 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q2 2023, down from 21 in Q1 2023.
- Funds reported $291K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q2 2023, down 95% quarter-over-quarter.
- 2 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q2 2023 and 3 closed out, a net change of -1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q2 2023 was ION Crossover Partners, an estimated $118K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q2 2023 was BAMCO Inc, an estimated $3.99M sold.
Based on aggregated 13F filings for Q2 2023.